Replies to post #658004 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Told people that the real money is with dcvax direct. Experimenting with 12 different types of cancers is huge especially with already promising phase 1 data. Now I'm in it to the end good luck you all.

They ran a P1/2 trial 10 years ago.

The secondary efficacy endpoint was ORR, and the P1 phase showed 0 ORR.

The phase 2 portion of the trial that was designed to enroll the cancers that showed the best response never launched.